Study: Higher Out-of-Pocket Costs Lead to Nonadherence
A literature review by AmerisourceBergen's Xcenda identifies a link between high cost sharing and patient nonadherence to medication regimens. The higher the cost-sharing burden health plans place on patients, the more impact there is on adherence and persistence, according to a recent study by Xcenda published in the Journal of Managed Care + Specialty Pharmacy. But the study found little evidence on the impact of high cost-sharing on outcomes.
For the full article, please visit Formulary Watch.